Use of an ATP bioluminescent assay to evaluate viability of Pneumocystis carinii from rats.
about
Cdc42 and RhoB activation are required for mannose receptor-mediated phagocytosis by human alveolar macrophagesEffects of atovaquone and diospyrin-based drugs on the cellular ATP of Pneumocystis carinii f. sp. cariniiInhibitors of sterol biosynthesis and amphotericin B reduce the viability of pneumocystis carinii f. sp. cariniiIn vitro and in vivo effects of quinupristin-dalfopristin against Pneumocystis cariniiInhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugsHighly active anti-Pneumocystis carinii compounds in a library of novel piperazine-linked bisbenzamidines and related compounds.The lipids of Pneumocystis carinii.Time between inoculations and karyotype forms of Pneumocystis carinii f. sp. Carinii influence outcome of experimental coinfections in ratsPneumocystis activates human alveolar macrophage NF-kappaB signaling through mannose receptorsIn vitro selection and in vivo efficacy of piperazine- and alkanediamide-linked bisbenzamidines against Pneumocystis pneumonia in mice.Effects of steroidal allenic phosphonic acid derivatives on the parasitic protists Leishmania donovani, Leishmania mexicana mexicana, and Pneumocystis carinii cariniiA cytotoxicity assay for evaluation of candidate anti-Pneumocystis carinii agents.Signal transduction in Pneumocystis carinii: characterization of the genes (pcg1) encoding the alpha subunit of the G protein (PCG1) of Pneumocystis carinii carinii and Pneumocystis carinii ratti.SYTO-13, a Viability Marker as a New Tool to Monitor In Vitro Pharmacodynamic Parameters of Anti-Pneumocystis DrugsGlucose triggers ATP secretion from bacteria in a growth-phase-dependent mannerBiofilm formation by Pneumocystis sppContinuous axenic cultivation of Pneumocystis cariniiPneumocystis melanins confer enhanced organism viability.Validation of ATP bioluminescence as a tool to assess antimicrobial effects of mouthrinses in an in vitro subgingival-biofilm model.
P2860
Q24557445-8E4EA424-0441-45FD-A403-0BF655F1D696Q28343926-83A64A6C-B4FA-4067-87F9-A20E3184CACCQ28344287-23379C43-1995-4492-8D4D-78D6A15CA566Q28361588-D4F81756-EBB3-4A78-99CC-62C670F30879Q28367376-A954A200-DC55-49DD-8EB5-5D1098BCA06EQ33208279-3B3A393E-622C-419D-BFB5-234155DE970AQ33992408-93E4FC89-6850-475C-A699-B86BC8B6D472Q34005499-CE439430-1C94-430C-8685-416AD2E8DBBBQ34145254-1EB8A364-48EA-46EC-9AE6-08AF68E57A3CQ34721573-5D3AE7F9-2891-4E20-A508-59D61518A341Q35131510-66F91531-0545-469F-8EA7-DE2AA1C2E903Q35132441-78EE4039-4DF1-4D21-ABC0-49F91A778774Q35471073-64E051B5-9790-4BDF-8498-5BCE6B748CE3Q35672089-37AFA030-0CE4-4BAD-9AE0-F0C1A975CD3DQ36757348-279A3771-A30A-4877-BA8C-AC416F7FB06CQ37099386-BE7F4143-DB13-4E71-9AE6-FE391DCDDB1AQ37185594-C8376955-AC8A-4C6D-A23A-8626A17F2601Q41488231-61D87644-C100-47C4-A8D1-41F81BDD8F49Q41837260-AE39097D-13CA-4498-91C6-293756B6D946
P2860
Use of an ATP bioluminescent assay to evaluate viability of Pneumocystis carinii from rats.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Use of an ATP bioluminescent a ...... neumocystis carinii from rats.
@en
Use of an ATP bioluminescent a ...... neumocystis carinii from rats.
@nl
type
label
Use of an ATP bioluminescent a ...... neumocystis carinii from rats.
@en
Use of an ATP bioluminescent a ...... neumocystis carinii from rats.
@nl
prefLabel
Use of an ATP bioluminescent a ...... neumocystis carinii from rats.
@en
Use of an ATP bioluminescent a ...... neumocystis carinii from rats.
@nl
P2860
P1476
Use of an ATP bioluminescent a ...... Pneumocystis carinii from rats
@en
P2093
P2860
P304
P407
P577
1994-11-01T00:00:00Z